ERCC1 and ovarian carcinoma: The observation that the ratios of larger ERCC1 relative to total ERCC1 mRNA significantly increased in ovarian cancer cells but not normal cells following cisplatin treatment implied cisplatin may preferentially induce the expression of larger ERCC1 rather than the regular transcript in ovarian cancer cells.